Prior authorizations and paperwork are killing medical providers; the good news is that a new CMS rule may lessen the burden.
The Centers for Medicare & Medicaid Services (CMS) has announced that they have finalized the CMS Interoperability and Prior Authorization Final Rule, designed to improve prior authorization processes and reduce burden on patients, providers, and payers, with a resultant $15 billion of estimated savings over ten years.
All News
Article
Article
Fertility and Rheumatoid Onset
MedPage Today
British women whose capability of bearing children either started late or ended early -- naturally or otherwise -- were at increased risk for developing rheumatoid arthritis (RA), compared with women with earlier menarche or later menopause, researchers found.
IL-17 pathway as a target in giant cell arteritis - full read review of pathogenic role of IL-17 and Th17 cells, in #GCA; backed up by the phase II proof-of-principle TiTAIN study showing potential efficacy of secukinumab in GCA pts https://t.co/2qX1F6ZP6J https://t.co/zoknjDgMQy
QD Clinic - Suspend MTX How Long?
Pregnancy and MTX - how long do you have to be off?
https://t.co/pTz8nlHpWN https://t.co/YrG7cKgbvF
QD Clinic - To Aspirate or Not
RA patient in need to an injection; do you aspirate first?
https://t.co/lOA5glSmfs https://t.co/FUvBFa8H7Q
Excited to be talking at https://t.co/hposbnLVdD!!
As usual, @RheumNow screen-grabbed me at an opportune moment 🤣😆
Highly recommend the conference; register live/online at the link above! https://t.co/XewJXRASi8
2023 EULAR Non-pharmacological Management of Hip and Knee Osteoarthritis: 2023 update
EULAR has published the 2023 updated recommendations for the optimal non-pharmacological management of hip and knee osteoarthritis (OA).
https://t.co/B7hE9jaGuo https://t.co/WCZ0VNcdKR
Mayo study shows multimorbidity in RA increases serious infx (SI) risk; 911 RA pts (56 yrs, 2/3 seropositive) 17% had SI (3.9/100PY). Hi risk morbidities(bipolar Dz, CKD, COPD,, chr skin ulcers) were assoc w/ 3 to 5-fold increased SI risk https://t.co/qorKp96KTm https://t.co/o5FaMKMskA
Japanese retrospective study compared RA pts on JAK inhib vs bDMARDs (n=62 ea) having orthopedic surgery; JAKi- pts had more postoperative flares (29% v 12%, P=.01), esp if JAKi held >11d (p.04). No diff in other postop complications https://t.co/E2fJS3N7KU https://t.co/4H00TgXVr2
What do you know about monogenic and polygenic autoinflammatory diseases? Join Drs Liebowitz and Mehta as they review the challenges of these conditions. https://t.co/TXJbpD3yB4 https://t.co/QGDaZdqrqz
Retrospective cohort compared 6147 new PsA pts vs 23,999 contros PsA. The uveitis risk was significantly higher in PsA (adj HR 2.38). Uveitis risk in PsA higher with prior uveitis (adj OR 136.4) and etanercept Rx (aOR 2.57). 106/107 Rx w/ topical steroids https://t.co/JSQ4fXpXja https://t.co/kl2JWcLBih
Prior RCT showed continuous NSAID slowed XRay progress in SpA. New 2 yr RCT of 109 pts shows when celecoxib added to TNFi Rx (golimumab) in high risk SpA there was no added Xray benefits (by mSASSS). https://t.co/i0KTPAaLFz https://t.co/dB2Q3PHhcK
You can still attend RheumNow Live!
Below is a preview of one of our "STEP" talks - by Mike Putman, MD, who brings his vast knowledge to the forefront, shedding light on Myths & Mistakes on ANCA-Associated Vasculitis.
https://t.co/iklCv4JouH
Register: https://t.co/ODaF07gP5s https://t.co/ToTpyQK4r4
Sodium Channels, Carbemazepine and Osteoarthritis Progression
A study published in Nature suggests that therapies affecting sodium channels could be employed to treat osteoarthritis.
https://t.co/P6Ef6N8eDC https://t.co/ASc34G5TBX
Increased CV Comorbidity in Dermatomyositis
A cohort study suggest that patients with dermatomyositis (DM) are at an increased risk for multiple comorbidities, including chronic kidney and cardiovascular disease,
https://t.co/8OhcLL5f6Y https://t.co/zVmyrx2DdI
Experience the Future of Rheumatology at RheumNow Live 2024, just two weeks away!
Don't miss out – secure your spot today for an unforgettable journey into the latest advancements and insights.
https://t.co/ny6R6QBq0j https://t.co/slHPPOQIDi
US Retrospective cohort study at 29 academic centers of 2428 adults hospitalized, of whom 550 (23%) had a diagnostic error (Pt assessment or testing) contributed to harm or death in 18%. 1863 pts died, w/ 6.6% having diagnostic error that contributed https://t.co/AN1sQt5A1h https://t.co/ZcDbxcoVWJ
Burnout! A cross-sectional study of 3024 US physicians, 60% took <=3 weeks of vacation per year, and 70.4% worked while on vacation on a typical vacation day; both findings were associated with higher rates of burnout. https://t.co/M3iFxKNoSE https://t.co/bc6WBkg7Ff
While NSAID use has been assoc w/ lower risk of cancers (CNS, breast, esophageal, gastric, head & neck, hepatocellular, cholangiocarcinoma, colorectal, endometrial, lung, ovary, prostate, pancreatic); NSAIDs should not be used to prevent cancers https://t.co/YcsU7x7iy0 https://t.co/QJjHqjnuEo
Retrospective study of 170 #RA on TNFi (Inflx 53%, ADA 28%, CZP 19%). RF, CCP, Drug levels, anti-Drug Abs done.@6 mos HI baseline RF linked to lower drug levels for IFX & ADA; but not CZP. IFX/ADA Hi-RF pts had more dropouts vs CZP (80%/75%/33%, p=0.002) https://t.co/AIgJNkzcWu https://t.co/pQmfmLoFwe


